NetworkNewsBreaks

MondayAug 15, 2022 12:19 pm

NetworkNewsBreaks — Laredo Oil Inc. (LRDC) Subsidiary Acquires Mineral Rights in Core Development Areas in Montana

Laredo Oil (OTC: LRDC), an oil exploration and production company, through its wholly owned subsidiary Lustre Oil Company LLC, is acquiring mineral rights in northeastern Montana core development areas. According to the company, the company has increased its acreage in these key locations from 24,000 net acres to 45,246 gross and 37,932 net acres currently.  “Our acquisition strategy has allowed us to lease acreage in the Western Williston Basin in Montana at what we believe to be a fraction of the cost of acreage in other comparable basins,” said Laredo Oil chair and CEO Mark See in the press release.…

Continue Reading

MondayAug 15, 2022 12:12 pm

NetworkNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Announces Entry into Revolving Credit Facility, Launch of Stock Portfolio Tracker

SRAX (NASDAQ: SRAX) is a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform. The company today announced its entry into a revolving credit facility as well as the launch of a website that allows investors to track the current value of SRAX’s marketable securities portfolio. “We are working diligently with our auditors to get our 10K filled. As of this date, there are no significant deviations (+/- 3%) on the income statement that we presented in our annual update. Our auditors have told us they believe that we will be…

Continue Reading

MondayAug 15, 2022 11:57 am

NetworkNewsBreaks – LFTD Partners Inc. (LIFD) Releases Q2 2022 Financial Report

LFTD Partners (OTCQB: LIFD), the corporate parent of leading cannabis and psychedelics manufacturer Lifted Made, is reporting on its second quarter 2022, which is the period ended June 30, 2022. Highlights of the report include revenue for the quarter totaling $16,776,502, a 151% increase from the $6,695,144 reported in Q2 2021, and an increase in operating margin of 3.14%, with Q2 2022 coming in at 26.40%. GAAP net income from the quarter increased — the eighth consecutive quarter of upward movement — totaling $3,219,460 up from $1,596,154 the same period last year. The company reported a 64% increase in basic…

Continue Reading

MondayAug 15, 2022 11:32 am

NetworkNewsBreaks – Investor Summit Group Kicks Off Q3 Investor Summit Tomorrow

Investor Summit Group ("ISG"), which has built a reputation for organizing some of North America’s largest and most reputable independent investor conferences, is hosting this week’s Q3 Investor Summit. The event, presented in an easy-to-use and attendee-friendly virtual format, is scheduled for Aug. 16–17, 2022; ISG presents quarterly investment summits that connect carefully curated companies and well-established management teams with qualified investors to further industry networks, explore potential synergies and forge lasting relationships. According to the announcement, the Investor Summit event series focuses on connecting leading small and micro companies with qualified individuals and entities looking to invest in the…

Continue Reading

FridayAug 12, 2022 2:50 pm

NetworkNewsBreaks – Embrace Change Acquisition Corp. (NASDAQ: EMCGU) Announces $65M IPO

Embrace Change Acquisition Corp. (NASDAQ: EMCGU), a blank check company newly incorporated as a Cayman Islands exempted company, recently announced the pricing of its initial public offering of 6,500,000 units, each at a price of $10.00, with each unit consisting of one ordinary share, one redeemable warrant and one right. Each redeemable warrant entitles the holder to purchase one ordinary share at a price of $11.50 per share, and each right entitles the holder to acquire one-eighth of an ordinary share. The units have commenced trading on the Nasdaq Global Market under the ticker symbol EMCGU, with the IPO expected…

Continue Reading

FridayAug 12, 2022 2:49 pm

NetworkNewsBreaks – Silo Pharma Inc.’s (SILO) Ketamine Study Generates ‘Extremely Promising’ Data

Silo Pharma (OTCQB: SILO), a development-stage biopharmaceutical company, recently completed an animal study of its ketamine formulation, showing nerve pain reduction when administered using a patented delivery system developed in partnership with Zylo Therapeutics. “Results from the small animal study produced positive endpoint results, demonstrating that Silo’s topical ketamine formulation reduced mechanical allodynia and hyperalgesia at both the pre- and post-dosing time points. Mechanical hyperalgesia was additionally reduced on day seven at the pre-dose time point. ‘These positive results of our study show that Silo is able to successfully formulate and deliver ketamine topically at reduced dosage to achieve its…

Continue Reading

FridayAug 12, 2022 1:32 pm

NetworkNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Looking to Solve Medical Challenge in Immune Responses

Aditxt (NASDAQ: ADTX) has sought to address a medical conundrum: approximately 50% of all transplanted organs are rejected by the host’s body within 10-12 years despite a wide array of medical innovations in recent years. This highlights the critical need for a practical, cost-effective solution to harmful immune responses. Aditxt is looking to solve this medical problem “through the creation of immune reprogramming technologies, which are being developed to retrain the immune system to induce tolerance to transplanted organs, self-tissues (autoimmune diseases) and allergens,” a recent article reads. “While still at a pre-clinical stage, ADi(TM) (Apoptotic DNA Immunotherapy), the company’s…

Continue Reading

FridayAug 12, 2022 1:10 pm

NetworkNewsBreaks – Friendable Inc.’s (FDBL) 360-Degree Offering Promoting Artists’ Independence, Revenue Generation

Friendable (OTC: FDBL), a mobile technology and marketing company, announced its acquisition of Artist Republik and FeaturedX in January 2022, bringing together a 360-degree suite of services for artists. The acquisition completed the company’s flagship offering, Fan Pass Live. “Artists can now sign up for the Fan Pass Live artist platform and benefit from music production, distribution and marketing services without the control of music labels pulling the strings or eating up revenue… The 360-degree suite of Fan Pass Live, Artist Republik and FeaturedX promotes being an independent label in an artist’s pocket, meaning there are no gatekeepers, no middleman,…

Continue Reading

FridayAug 12, 2022 12:42 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Positioning Berubicin Clinical Development Program for Success

CNS Pharmaceuticals (NASDAQ: CNSP) is currently recruiting patients for a phase II study evaluating the efficacy and safety of Berubicin, its lead drug candidate for treating glioblastoma multiforme (“GBM”), the most aggressive, deadly and treatment-resistant type of cancer that forms in the brain. Recently, the company announced that the FDA had approved an amendment to the study’s protocol, boosting its Berubicin clinical development program. “The amendment expands eligibility for its potentially pivotal study to patients who have received additional treatments as part of the first-line therapy,” explains a recent article. “The key objectives of the amendment, according to CNS Pharmaceuticals…

Continue Reading

FridayAug 12, 2022 12:09 pm

NetworkNewsBreaks – Cub Crafters Inc. Featured in APOA Article

Cub Crafters (typically styled CubCrafters), the leading designer and manufacturer of light-sport, experimental and Part 23 certified backcountry aircraft, was featured in a recent article published by the APOA Foundation. The piece highlights CubCrafters’ unveiling of its Carbon Cub EX–2 engine upgrade, as well as its plan to raise millions to speed up production and aircraft development. The article reads, “CubCrafters Vice President of Sales and Marketing Brad Damm said customers asked for a fuel-injected variant with a fixed-pitch propeller: ‘So, this is a new engine for us. Based on the previous IO-360 engine that we had. We’ve lightened it up a…

Continue Reading